TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05610085: A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

Sponsor: University of California, San Diego · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 133 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$10,514,800

Rescue Site Savings

+$6,945,200

Unlock Full NCT05610085 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05610085 Rescue Dossier →